T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
ProKidney
PROK
$387M
| $127K | ﹤0.01% |
+62,039
| New | +$114K |
|
3102
Children's Place
PLCE
$56.5M
| $126K | ﹤0.01% |
41,266
+17,727
| +75% | +$60.1K |
|
3103
BCB Bancorp
BCBP
$156M
| $125K | ﹤0.01% |
11,648
+695
| +6% | +$7.09K |
|
3104
Protalix BioTherapeutics
PLX
$215M
| $125K | ﹤0.01% |
53,478
| – | – |
|
3105
Smart Sand
SND
$229M
| $125K | ﹤0.01% |
+24,764
| New | +$124K |
|
3106
TTEC Holdings
TTEC
$62.6M
| $125K | ﹤0.01% |
64,363
+11
| +0% | +$28 |
|
3107
ProFrac Holding
ACDC
$998M
| $122K | ﹤0.01% |
20,888
| – | – |
|
3108
Prelude Therapeutics
PRLD
$406M
| $122K | ﹤0.01% |
+22,758
| New | +$99.1K |
|
|
WHWK
3109
Whitehawk Therapeutics
WHWK
$239M
| $122K | ﹤0.01% |
+26,609
| New | +$111K |
|
3110
1-800-Flowers.com
FLWS
$224M
| $121K | ﹤0.01% |
34,649
| – | – |
|
3111
AEye
LIDR
$61.8M
| $121K | ﹤0.01% |
83,857
+19,477
| +30% | +$35.2K |
|
3112
Foghorn Therapeutics
FHTX
$277M
| $120K | ﹤0.01% |
24,478
| – | – |
|
3113
Amplify Energy
AMPY
$204M
| $119K | ﹤0.01% |
+29,709
| New | +$153K |
|
3114
Lifecore Biomedical
LFCR
$155M
| $119K | ﹤0.01% |
22,560
+4,880
| +28% | +$24.6K |
|
3115
LifeMD
LFMD
$143M
| $119K | ﹤0.01% |
28,579
| – | – |
|
3116
FreightCar America
RAIL
$221M
| $119K | ﹤0.01% |
+12,181
| New | +$103K |
|
3117
Ampco-Pittsburgh
AP
$175M
| $117K | ﹤0.01% |
+13,488
| New | +$137K |
|
3118
Soluna Holdings
SLNH
$303M
| $117K | ﹤0.01% |
+85,983
| New | +$124K |
|
3119
Security National Financial
SNFCA
$226M
| $117K | ﹤0.01% |
12,617
| – | – |
|
3120
CAMP4 Therapeutics
CAMP
$272M
| $116K | ﹤0.01% |
+26,327
| New | +$114K |
|
|
AIRO
3121
AIRO Group Holdings
AIRO
$217M
| $116K | ﹤0.01% |
15,631
+1,158
| +8% | +$9.07K |
|
3122
Vivid Seats
SEAT
$55.3M
| $114K | ﹤0.01% |
17,400
-1,778
| -9% | -$13.6K |
|
|
PAL
3123
Proficient Auto Logistics
PAL
$141M
| $114K | ﹤0.01% |
16,618
+982
| +6% | +$6.57K |
|
3124
Cartesian Therapeutics
RNAC
$263M
| $113K | ﹤0.01% |
+10,758
| New | +$79.7K |
|
3125
Epsilon Energy
EPSN
$189M
| $108K | ﹤0.01% |
19,933
+1,633
| +9% | +$9.68K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.